• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性脂肪性肝炎(ASH)和酒精性肝炎(AH):级联事件、临床方面和药物治疗选择。

Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options.

机构信息

a Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Academic Teaching Hospital of the Medical Faculty , Goethe University Frankfurt/Main , Frankfurt/Main , Germany.

出版信息

Expert Opin Pharmacother. 2018 Jun;19(8):779-793. doi: 10.1080/14656566.2018.1465929. Epub 2018 Apr 30.

DOI:10.1080/14656566.2018.1465929
PMID:29708448
Abstract

INTRODUCTION

Clinicians caring for patients with alcoholic hepatitis (AH) are often confronted with the question of the best pharmacotherapy to be used.

AREAS COVERED

This article covers metabolic aspects of alcohol as the basis of understanding pharmacotherapy and to facilitate choosing the drug therapeutic options for patients with severe AH.

EXPERT OPINION

Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH) as terms are often used interchangeably in scientific literature but a stringent differentiation is recommended for proper clarity. As opposed to ASH, the clinical course of AH is often severe and requires an effective drug treatment strategy, in addition to absolute alcohol abstinence and nutritional support. Drug options include corticosteroids as a first choice and pentoxifylline, an inhibitor of phosphodiesterase, as a second line therapy, especially in patients with contraindications for a corticosteroid therapy such as infections or sepsis. At seven days under corticosteroids, treatment should be terminated in non-responders, and patients must then be evaluated for liver transplantation. Pentoxifylline is not effective as a rescue therapy for these patients. Other treatments such as infliximab, propylthiouracil, N-acetylcysteine, silymarin, colchicine, insulin and glucagon, oxandrolone, testosterone, and polyunsaturated lecithin are not effective in severe AH. For liver transplantation, few patients will be eligible.

摘要

简介

治疗酒精性肝炎(AH)患者的临床医生经常面临选择最佳药物治疗的问题。

涵盖领域

本文涵盖了酒精的代谢方面,作为理解药物治疗的基础,并为重症 AH 患者选择药物治疗方案提供便利。

专家意见

酒精性脂肪性肝炎(ASH)和酒精性肝炎(AH)这两个术语在科学文献中经常互换使用,但为了准确起见,建议严格区分。与 ASH 不同,AH 的临床病程通常较为严重,除了绝对戒酒和营养支持外,还需要有效的药物治疗策略。药物选择包括皮质类固醇作为首选,以及磷酸二酯酶抑制剂己酮可可碱作为二线治疗,特别是在皮质类固醇治疗有禁忌症(如感染或败血症)的患者中。如果在皮质类固醇治疗七天后没有应答,应终止治疗,此时必须评估患者是否适合进行肝移植。对于这些患者,己酮可可碱无效作为抢救治疗。其他治疗方法,如英夫利昔单抗、丙硫氧嘧啶、N-乙酰半胱氨酸、水飞蓟素、秋水仙碱、胰岛素和胰高血糖素、氧雄龙、睾酮和多不饱和卵磷脂,对重症 AH 均无效。对于肝移植,只有少数患者符合条件。

相似文献

1
Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options.酒精性脂肪性肝炎(ASH)和酒精性肝炎(AH):级联事件、临床方面和药物治疗选择。
Expert Opin Pharmacother. 2018 Jun;19(8):779-793. doi: 10.1080/14656566.2018.1465929. Epub 2018 Apr 30.
2
Update on the management of alcoholic steatohepatitis.酒精性脂肪性肝炎的治疗进展。
J Gastrointestin Liver Dis. 2013 Jun;22(2):189-97.
3
Alcoholic hepatitis: Prognosis and treatment.酒精性肝炎:预后与治疗
Gastroenterol Hepatol. 2014 Apr;37(4):262-8. doi: 10.1016/j.gastrohep.2014.02.001. Epub 2014 Mar 20.
4
Pharmacotherapy of acute alcoholic hepatitis in clinical practice.急性酒精性肝炎的临床药物治疗
World J Gastroenterol. 2014 Mar 7;20(9):2159-67. doi: 10.3748/wjg.v20.i9.2159.
5
[Diagnostic and therapeutic strategies for severe alcoholic hepatitis].[重症酒精性肝炎的诊断与治疗策略]
Korean J Gastroenterol. 2015 Jan;65(1):4-11. doi: 10.4166/kjg.2015.65.1.4.
6
Prognosis and treatment of patients with acute alcoholic hepatitis.急性酒精性肝炎患者的预后与治疗
Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):471-86. doi: 10.1586/17474124.2014.903800. Epub 2014 Apr 10.
7
A prognostic evaluation and management of alcoholic hepatitis.酒精性肝炎的预后评估与管理
Minerva Med. 2017 Dec;108(6):554-567. doi: 10.23736/S0026-4806.17.05136-9. Epub 2017 Jun 9.
8
Therapeutic Strategies for the Treatment of Alcoholic Hepatitis.酒精性肝炎的治疗策略
Semin Liver Dis. 2016 Feb;36(1):56-68. doi: 10.1055/s-0036-1571297. Epub 2016 Feb 12.
9
Review article: the diagnosis and management of alcoholic hepatitis.综述文章:酒精性肝炎的诊断与治疗。
Aliment Pharmacol Ther. 2009 Jul;30(1):3-13. doi: 10.1111/j.1365-2036.2009.04002.x. Epub 2009 Mar 26.
10
[Is there a role for pentoxifylline in the treatment of alcoholic hepatitis?].己酮可可碱在酒精性肝炎治疗中有作用吗?
Gastroenterol Hepatol. 2016 Oct;39(8):560-5. doi: 10.1016/j.gastrohep.2015.10.004. Epub 2015 Nov 15.

引用本文的文献

1
Hepatoprotective Effect of Mycelium Powder on Alcohol-Induced Liver Damage.菌丝体粉对酒精性肝损伤的保护作用。
Nutrients. 2024 Oct 8;16(19):3406. doi: 10.3390/nu16193406.
2
The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD.肠道微生物群、外泌体及其相互作用在酒精性肝病发病机制中的作用。
J Adv Res. 2025 Jun;72:353-367. doi: 10.1016/j.jare.2024.07.002. Epub 2024 Jul 3.
3
Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury.
铜、铁、镉、砷,宇宙中全部生成:阐明其对人类健康包括临床肝损伤的环境影响风险。
Int J Mol Sci. 2024 Jun 17;25(12):6662. doi: 10.3390/ijms25126662.
4
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives.MASH作为肝细胞癌的一种新兴病因:当前认知与未来展望。
Mol Oncol. 2025 Feb;19(2):275-294. doi: 10.1002/1878-0261.13685. Epub 2024 Jun 14.
5
Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.威尔逊病:铜介导的铜死亡、铁相关的铁死亡,以及临床重点,并进行全面和批判性分析更新。
Int J Mol Sci. 2024 Apr 26;25(9):4753. doi: 10.3390/ijms25094753.
6
Network medicine-based analysis of the hepatoprotective effects of Lour. on alcoholic liver disease in rats.基于网络医学对 Lour. 对大鼠酒精性肝病保肝作用的分析。 (注:这里Lour.不太明确具体所指,可能是某种特定物质、药物等,需结合更完整的原文信息准确理解)
Food Sci Nutr. 2024 Feb 22;12(5):3759-3773. doi: 10.1002/fsn3.4046. eCollection 2024 May.
7
regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice.调节肠道微生物群并改善小鼠酒精性肝病。
Front Microbiol. 2024 Feb 26;15:1337185. doi: 10.3389/fmicb.2024.1337185. eCollection 2024.
8
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.酒精、炎症与酒精性肝病中的微生物组。
Int J Mol Sci. 2023 Feb 13;24(4):3735. doi: 10.3390/ijms24043735.
9
Effects of beer, wine, and baijiu consumption on non-alcoholic fatty liver disease: Potential implications of the flavor compounds in the alcoholic beverages.啤酒、葡萄酒和白酒消费对非酒精性脂肪性肝病的影响:酒精饮料中风味化合物的潜在影响。
Front Nutr. 2023 Jan 6;9:1022977. doi: 10.3389/fnut.2022.1022977. eCollection 2022.
10
Aging of Liver in Its Different Diseases.肝脏在不同疾病中的老化。
Int J Mol Sci. 2022 Oct 28;23(21):13085. doi: 10.3390/ijms232113085.